Identification of a family of alternatively spliced mRNA species of angiopoietin-1

Blood

Volumn 95, Issue 6, 2000, Pages 1993-1999

  Huang, Yao Qi ^a   Li, Jian Jun ^a   Karpatkin, Simon ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; MESSENGER RNA; TYROSINE KINASE RECEPTOR;

ALTERNATIVE RNA SPLICING; ANGIOGENESIS; ARTICLE; CANCER CELL; CELL DIFFERENTIATION; CELL GROWTH; ENDOTHELIUM CELL; FETUS LIVER; FIBROBLAST; GENE SEQUENCE; HEMATOPOIETIC CELL; IMMUNOBLOTTING; MEGAKARYOPOIESIS; MOLECULAR CLONING; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RIBONUCLEASE PROTECTION ASSAY; THROMBOCYTE;

EID: 0034653561     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.6.1993     Document Type: Article

References (29)

1. Basilico C, Moscatelli D. The FGF family of growth factors and oncogenes. Adv Cancer Res. 1992;59:115.
2. Ferrara, N, Davis-Smith T. The biology of vascular endothelial growth factor. Endocr Rev. 1997; 18:4.
3. Davis S, Aldrich TH, Jones PF, et al. Isolation of angiopoietin-1, a ligand for the TIE-2 receptor, by secretion-trap expression cloning. Cell. 1996;87: 1161
4. Sato TN, Qin Y, Kozak CA, Audus KL. Tie-1 and Tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system. Proc Natl Acad Sci U S A. 1993;90:9355.
5. Iwama A, Hamaguchi I, Hashiyama M, Murayama Y, Yasunaga K, Suda T. Molecular cloning and characterization of mouse Tie and Tek receptor tyrosine kinase genes and their expression in hematopoietic stem cells. Biochem Biophys Res Commun. 1993;195:301.
6. Korhonen J, Polvi A, Partanen J, Alitalo K. The mouse Tie receptor tyrosine kinase gene: expression during embryonic angiogenesis. Oncogene. 1994;9:395.
7. Sato TN, Tozawa Y, Deutsch U, et al. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature. 1995; 376:70.
8. Suri C, Jones PF, Patan S, et al. Requisite role of angiopoietin-1, a ligand for the Tie-2 receptor, during embryonic angiogenesis. Cell. 1996;87: 1171.
9. Witzenbichler B, Maisonpierr PC, Jones P, Yancopoulos GD, Isner JM. Chemotactic properties of Angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie-2. J Biol Chem. 1998;273:18,514.
10. Koblizek TI, Weiss C, Yancopoulos GD, Deutsch U, Risau W. Angiopoietin-1 induces sprouting angiogenesis in vitro. Curr Biol. 1998;8:529.
11. Suri C, McClain J, Thurston G, et al. Increased vascularization in mice overexpressing angiopoietin-1. Science. 1998;282:468.
12. Maisonpierre PC, Suri C, Jones PF, et al. Angiopoietin-2, a natural antagonist for Tie-2 that disrupts in vivo angiogenesis. Science. 1998; 277:55.
13. Shyu KG, Manor O, Magner M, Yancopoulos GD, Isner JM. Direct intramuscular injection of plasmid DNA encoding angiopoietin-1 but not angiopoietin-2 augments revascularization in the rabbit ischemic hindlimb. Circulation. 1998;98:2081.
14. Asahara T, Chen D, Takahashi T, et al. Tie-2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circ Res. 1998;83:233.
15. Patanen J, Makela TP, Alitalo R, Lehvaslaiho H, Alitolo K. Putative tyrosine kinases expressed in K-562 human leukemia cells. Proc Natl Acad Sci U S A. 1990;87:8913.
16. Armstrong E, Korhonen J, Silvennoinen O, Cleveland JL, Lieberman MA, Alitalo R. Expression of Tie receptor tyrosine kinase in leukemia cell lines. Leukemia. 1993;7:1585.
17. Hashiyama M, Iwama A, Ohshiro K, et al. Predominant expression of a receptor tyrosine kinase, Tie, in hematopoietic stem cells and B cells. Blood. 1996;87:93.
18. Batard P, Sansilvestri P, Scheicker C, et al. The Tie receptor tyrosine kinase is expressed by human hematopoietic progenitor cells and by a subset of megakaryocytic cells. Blood. 1996;87:2212.
19. Partanen J, Puri MC, Schwartz L, Fisher KD, Bernstein A, Rossant J. Cell autonomous functions of the receptor tyrosine kinase Tie in a late phase of angiogenic capillary growth and endothelial survival during murine development. Development. 1996;122:3013.
20. Sato A, Iwama A, Takakura N, Nishio H, Yancopoulos GD, Suda T. Characterization of TEK receptor tyrosine kinase and its ligands, angiopoietins, in human hematopoietic progenitor cells. Int Immunol. 1998;10:1217.
21. + bone marrow cells) are enriched with megakaryocytes expressing CD4. Blood. 1996;87:1353-1360.
22. Lupas A. Coiled coils: new structures and new functions. Trends Biochem Sci. 1996;21:375.
23. Doolittle RF. Fibrinogen and fibrin. Ann Rev Biochem. 1984;53:195.
24. Kammerer RA, Schulthess T, Landwehr R, Lusting A, Fisher D, Engel J. Tenascin-C hexabrachion assembly is a sequential two-step process initiated by coiled-coils alpha-helices. J Biol Chem. 1998;273:10,602.
25. Lauren J, Gunji Y, Alitalo K. Is angiopoietin-2 necessary for the initiation of tumor angiogenesis? Am J Pathol. 1998;153:1333.
26. Ferrara N. Vascular endothelial growth factor: molecular and biological aspects. Curr Top Microbiol Immunol. 1999;237:173.
27. Valenzuela DM, Griffiths JA, Rojas J, et al. Angiopoietin 3 and 4: diverging gene counterparts in mice and humans. Proc Natl Acad Sci U S A. 1999;96:1904.
28. Lin P, Polverini P, Dewhirst M, Shan S, Rao PS, Peters K. Inhibition of tumor angiogenesis using soluble receptor establishes a role for Tie-2 in pathological vascular growth. J Clin Invest. 1997; 100:2072.
29. Lin P, Buxton J, Acheson A, et al. Anti-angiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie-2. Proc Natl Acad Sci U S A. 1998;95:8829.